Market & Policy Chronology · 1983–2026
How Ontario's IVF market moved from a de-insured, hospital-based service to a publicly co-funded industry now being consolidated by private equity — clinics, funding, and the pandemic year that accelerated it all. Includes a Mount Sinai Fertility thread woven through in plum.
IVF in Ontario starts inside teaching hospitals, gets de-insured in the '90s, and slowly spins out into independent, physician-owned clinics.
Toronto East General Hospital (now Michael Garron Hospital) recorded Canada's first confirmed IVF pregnancy the same year a UBC patient delivered the country's first IVF birth, on Christmas Day 1983 — the starting point for organized IVF practice in Ontario.
The province removes general IVF coverage from public health insurance, keeping a narrow exception only for complete bilateral fallopian tube blockage. IVF becomes almost entirely a private-pay service for the next two decades.
Programs originally embedded in institutions like Mount Sinai and the Ottawa Civic begin separating into independent, physician-owned practices for operational flexibility — the structural shift that later makes the sector acquirable.
Before Dr. Robert Casper left to found TRIO Fertility (with Dr. Ken Cadesky and Dr. Carl Laskin), Mount Sinai's fertility was operated under a different name - "The Centre for Ferility and Reproductive Health." Exact former name and date unconfirmed in public sources.
A provincial expert panel, including Dr. Ellen Greenblatt, recommends Ontario significantly expand IVF funding and mandate single-embryo transfer, citing cost as the primary barrier to care — the blueprint the government adopts six years later.
The Royal College of Physicians and Surgeons of Canada (RCPSC) formally recognizes Gynecologic REI as an official subspecialty. Mount Sinai's program is among the foundational programs standardized under these national guidelines. [source]
Public funding returns for the first time in over 20 years — and immediately runs into demand it wasn't sized for.
Health Minister Eric Hoskins announces roughly $50 million a year in new funding for one publicly funded IVF cycle plus unlimited funded IUI, for OHIP-eligible people under 43 — the policy that becomes the Ontario Fertility Program (OFP). Funding comes from Ontario Health.
The province details the network of roughly 50 participating clinics and hospitals expected to deliver the program, alongside the mandatory single-embryo-transfer rule designed to cut costly multiple-birth complications.
Funded cycles begin province-wide. It is the first general public IVF funding in Ontario since the 1994 delisting.
Demand for funded cycles far exceeds capacity, producing wait lists reported as long as three years. Several clinics adopt lottery-style systems to allocate limited funded slots fairly among patients.
The first births conceived through publicly funded cycles arrive, roughly ten months after the program opened.
The province marks one year of the program, reporting more than 6,500 people funded to date and projecting up to $500M in avoided health costs over a decade from fewer multiple-birth complications under the single-embryo-transfer rule.
Dr. Marjorie Dixon founds Anova in Toronto. It grows into one of the GTA's larger independent clinics before taking private-equity backing three years later.
Leadership considers relocating the clinic and decides to postpone: the lease is extended and the 4th floor is renovated instead.
Health Canada's Reimbursement Related to Assisted Human Reproduction Regulations come into force, finally clarifying which surrogate and donor expenses can legally be reimbursed under the 2004 Assisted Human Reproduction Act — directly shaping third-party family building through Ontario clinics.
Persistence Capital Partners, a Canadian healthcare-focused PE firm, invests in Anova to fund new clinics and expansion — an early signal of institutional capital moving into Ontario fertility care.
Evans, MSF's Managing Director, leaves. He later takes the same role at Markham Fertility Centre.
The pandemic forces a province-wide shutdown of fertility care — and the same year, the first national private-equity platform launches out of Toronto.
The Canadian Fertility & Andrology Society advises caution around non-essential travel and flags that pregnancy increases susceptibility to respiratory infection — the first in a long run of pandemic guidance to Canadian clinics.
CFAS directs clinics to move consultations to telemedicine and suspend all diagnostic and elective procedures, pausing new cycle starts except for urgent oncology fertility preservation. Ontario clinics, including Mount Sinai Fertility, halt active treatment.
Guidance shifts from suspension to restart planning on April 15, then a detailed resumption framework follows on May 13, once local safety criteria can be met.
Clinics across the province resume treatment in stages as case counts ease, with CFAS endorsing an ASRM/ESHRE/IFFS joint statement in June affirming reproductive care as essential healthcare.
Dr. Rhonda Zwingerman leaves Mount Sinai Fertility to establish an independent clinic called Twig.
Dr. Shannon Moore leaves Mount Sinai Fertility; she is now a physician at Hannam Fertility Centre.
Backed by Peloton Capital Management and Heal Partners, TFP launches as a national consolidation platform, acquiring seven founding clinics — including Procrea's Vaughan and Newmarket locations and Mississauga's Reproductive Care Centre. It's the start of large-scale private-equity roll-up in Canadian fertility care.
TRIO, one of Toronto's largest and best-known independent clinics, is acquired by the PE-backed Eugin Group — its first change of ownership, and not its last.
After more than a decade on staff — including leading Quality Improvement for the REI division — Dr. Rebecca Arthur leaves for Hannam Fertility Centre.
Nurse practitioner Eileen McMahon leaves for Hannam Fertility Centre; a past president of CFAS, the only non-physician in this role.
The Fertility Partners renames its Vaughan and Newmarket clinics — operating as Procrea since 2011 — to Generation Fertility, alongside the reopening of a larger, renovated Newmarket location.
Dr. Chan leaves Mount Sinai Fertility to become Scientific Director at Markham Fertility Centre, newly independent following its physician-led ownership change the same month.
Founder Dr. Michael Virro sells Markham Fertility Centre to three of his own physician leaders — Dr. Meivys Garcia (Medical Director), Dr. Marta Wais (Quality Director), and Dr. Crystal Chan (Scientific Director, joining from Mount Sinai Fertility). A rare case of an Ontario clinic changing hands through physician succession rather than a PE or network acquisition.
A dense run of acquisitions reshapes GTA and Ontario ownership, even as new venture-backed challenger clinics try to open alongside the roll-ups.
TFP extends its Ontario footprint east, folding one of the province's larger academically-affiliated clinics into its network.
Founded by CEO Nicole Condon and operating under the TRIO Fertility family, EVOLVE launches in Toronto as the country's first clinic dedicated solely to egg freezing, citing rising demand for fertility preservation — including a pandemic-era jump in interest.
Twig opens a full IVF and egg-freezing clinic and lab in Midtown Toronto (313 Eglinton Ave. W) — the first location for what becomes a fast-growing, tech-forward challenger to the established GTA players.
Kitchener Area Reproductive Medicine Associates joins the TFP network, extending the platform into southwestern Ontario.
The Toronto Institute for Reproductive Medicine and its affiliated sperm bank, ReproMed, join TFP — by this point TFP operates seven Ontario locations among 13 IVF centres nationally.
Denver-based CCRM Fertility enters Toronto by acquiring Dr. Tom Hannam's downtown clinic, rebranding it CCRM Fertility Toronto — the first major US network to establish a direct Ontario presence.
Dr. Bacal joins as Clinician-Investigator and Assistant Professor, with a focus on recurrent pregnancy loss and reproductive outcomes.
Dr. Pereira joins as Clinician-Investigator and Associate Professor. He later supervises Canada's first birth following a uterine transplant (reported Aug 2026).
Rhino Ventures leads an $8-million round into Twig, a tech-forward Toronto clinic — venture capital, not just PE roll-up money, entering the sector.
Anova expands its physical footprint in the city with a new downtown clinic, still independent of the PE roll-up platforms at this stage.
A new 20,000 sq. ft. flagship clinic opens at 2360 Yonge St. (Yonge & Eglinton), backed by $20 million from David Thomson's Osmington Inc. — another well-capitalized new entrant competing against the consolidating incumbents.
A global consolidation deal in genetic testing and embryo screening — infrastructure that Ontario IVF labs, including those doing PGT, rely on — signalling the roll-up extending past clinics into the supply chain.
The question of relocating the clinic is revisited, six years after being settled the first time.
Dr. Michaeli joins as Clinician-Investigator and Assistant Professor, with a research focus on oncofertility and fertility preservation.
Mount Sinai Fertility establishes its ovarian tissue cryopreservation (OTC) program — fertility preservation for patients facing treatment that threatens their fertility. The program's team later leads Canada's first published ovarian tissue transport case (CMAJ, Nov 2025).
Spain's IVI RMA (backed by KKR) completes a $535-million acquisition of Eugin Group's Boston IVF network and TRIO Fertility — TRIO's second change of ownership in three years.
Ontario now counts roughly 43 fertility clinics performing more than 7,700 privately funded IVF cycles annually (over $150M in private spend) — with close to a third of clinics tied to investor-backed networks rather than independent physician owners.
Twig adds a downtown, PATH-connected location at 130 King St. W — its first expansion beyond the Midtown flagship.
A decade after the OFP first launched, Queen's Park returns with its largest funding increases yet, naming clinics directly — while Twig and Pollin turn Toronto footholds into multi-city networks.
The province announces $150 million over two years to expand the OFP through hospitals and community clinics, aiming to roughly triple the number of families accessing government-funded fertility services — plus a new personal fertility tax credit for January 2025.
Residents can now claim 25% of eligible fertility expenses — IVF cycles, medications, diagnostic testing, and related travel — up to $5,000 per year, backed by $115 million over three years.
The Fertility Partners brand opens a Toronto West location — the former ReproMed Fertility site at 56 Aberfoyle Cres. in Etobicoke, near Islington Station — led by Dr. Violetta Buduryan.
For the second time since 2017, the relocation question is settled: postpone again, extend the lease to 2032, and renovate the 7th and 4th floors.
A further $250M ($50M for 2025/26, $200M through 2027/28) brings three previously private-pay GTA clinics — Pollin, Twig, and Tripod Fertility — onto the publicly funded roster for the first time. TRIO, Generation Fertility Toronto West, CReATe, Mount Sinai Fertility, and Hannam all receive expanded funded volumes. The eight Toronto clinics are expected to deliver roughly 2,250 IVF cycles combined; the OFP now spans 54 clinics province-wide.
Pollin extends outside the GTA for the first time, operating through the Neo Women's Health Network in Sudbury — part of the same expansion wave following its OFP funding. Exact opening date not confirmed in public sources.
Fresh acquisitions elsewhere in IVI RMA's North American network underline that the roll-up pressure on independent clinics — the kind that reshaped TRIO and Hannam — is still active going into 2026.
Twig's third location — after Midtown and Downtown Toronto — opens in Vancouver, its first outside Ontario, citing long wait times and a shortage of specialists and lab capacity in B.C.
Ontario allocates another $100 million across 27 clinics — including Halton Fertility and Women's Health Centre in Oakville — expected to fund roughly 10,000 additional IVF cycles this year. The OFP now supports 56 clinics province-wide, and Health Minister Sylvia Jones says the program has helped nearly 133,000 Ontarians build their families since its 2015 launch.
Consultations, diagnostic testing, cycle monitoring, and low-intervention treatment begin at Pollin's new Ottawa clinic; the embryology lab — enabling egg retrievals, transfers, and cryopreservation on-site — is expected to follow in late fall 2026.
A decade after independent physician-owners controlled 70–80% of Canadian fertility practices, that share has fallen to roughly 30% — the rest split between private-equity platforms, partnerships, and larger conglomerates.